ReviewArchives of toxicology2026
Ursolic acid: context-dependent redox activity on oxidative stress and its toxicological implications.
Review in Archives of toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Oxidative stress is a major contributor to xenobiotic-induced tissue injury, mitochondrial dysfunction, inflammation, ferroptosis, and carcinogenesis. Ursolic acid (UA), a naturally occurring pentacyclic triterpenoid, has emerged as a context-dependent regulator of redox homeostasis. This review summarizes current evidence regarding the dual effects of UA on oxidative stress and its toxicological implications. Under non-malignant conditions, UA generally exerts antioxidant and cytoprotective effects in the majority of experimental models examined. Reduced reactive oxygen species (ROS) accumulation, modulation of nuclear factor erythroid 2-related factor 2 (Nrf2)/Kelch-like ECH-associated protein 1 (Keap1) signalin, preservation of mitochondrial homeostasis, and attenuation of inflammatory and apoptotic responses appear to underlie these protective activities. Protective effects have been reported in experimental models of hepatic, renal, cardiovascular, neurological, and radiation-associated injury. By contrast, in tumor cells characterized by elevated basal oxidative stress, UA has frequently been shown to exert pro-oxidative actions, though this response is influenced by concentration, exposure duration, and cellular context. In malignant models, UA has been shown to enhance ROS accumulation, disturb redox balance, suppress antioxidant defenses, and promote cell death associated with ferroptosis and apoptosis, thereby increasing sensitivity to chemotherapy and radiotherapy. Despite promising preclinical findings, several limitations continue to restrict clinical translation, including poor oral bioavailability, variable pharmacokinetics, potential herb-drug interactions, and insufficient long-term toxicological evaluation. Overall, current evidence supports UA as a context-dependent redox modulator with dual antioxidant and pro-oxidant activities, although further mechanistic, pharmacokinetic, and translational studies remain necessary.
Indexed as
Identifiers
42834150What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.